Title for MeetingAbstracts

Alphabetical listing of titles

• Improved HIV/AIDS/STI serosurveillance among antenatal clinic enrollees in Tanzania, 2001-2002.
• Improved Human Immunodeficiency Virus 1 Gag and Pol Expression Cassettes.
• Improved human immunodeficiency virus 1 Gag and Pol vaccine antigens.
• Improved identification of Candida species-using biotinylated species-specific DNA probes.
• Improved Immunogenicity and Efficacy after Single- Dose Measles-Mumps-Rubella Vaccine at 12 Months in Comparison to Vaccination of Children with Measles Vaccine at 9 Months Followed by Measles-Mumps-Rubella Vaccine at 15 Months.
• Improved immunogenicity of HIV-1 gp160 expressed by vaccinia virus.
• Improved immunologic function correlates with CD4 rise after highly active anti-retroviral therapy (HAART).
• Improved in situ detection of HIV nucleic acid with fluorescent probes and laser excitation.
• Improved in vitro Survival of PBMC in GBV+ HIV-infected Patients: Role of Apoptosis and Cell Proliferation.
• Improved indexing of randomised controlled trials has enabled computer search strategies to identify them with high sensitivity and specificity, in pain relief research.
• Improved knowledge but unchanged behaviour following a safe sex intervention among prostitutes in Singapore.
• Improved Measurement of Antibody-Mediated Neutralization of HIV-1 by Flow Cytometric Enumeration of Infected T Cells.
• Improved method for the detection of ganciclovir in plasma using HPLC with electrochemical detection. Eleventh International Conference on Antiviral Research.
• Improved methods and measures for monitoring the quality of medical care.
• Improved methods for the preservation and culture of HIV from plasma.
• Improved neutralization of HIV-1 primary isolates.
• Improved nutritional status as a result of nutrition intervention in adult HIV+ outpatients.
• Improved outcome for HIV infected adults with bacteraemia and mycobacteraemia admitted to hospital in a resource poor setting; trends over the last decade.
• Improved outcome of HIV-infected patients with multidrug- resistant tuberculosis (MDRTB) in a nonoutbreak setting at an inner-city hospital in New York City.
• Improved outcome of MDR-TB in patients receiving a five or more drug initial therapy.
• Improved outcome of patients with CMV retinitis after adoption of 1996 IAS-USA recommendations.
• Improved outcomes from problem-service "matching" in substance abuse patients: a controlled study in a four-program, EAP network.
• Improved outcomes in a Cohort of HIV-infected patients with multi-drug-resistant tuberculosis enrolled in a directly observed therapy tuberculosis program.
• Improved outcomes in intensive care units for AIDS-related Pneumocystis carinii pneumonia from 15 veterans administration hospitals from 1987-1991. Western Region Special Studies Group.
• Improved Outcomes with Earlier Initiation of HAART: Longer Follow-up of an Observational Cohort Study.
• Improved partner notification activities in a South African mining community.
• Improved patient function in the rheumatoid arthritis population treated with anakinra (kineret) in a standard canadian clinical setting.
• Improved performance after implementation of a quality assurance program in a multisite perinatal HIV research initiative in Southern Brazil.
• Improved Physiologic and Metabolic Parameters and Increased Survival with Late Procalcitonin Immunoneutralization in Septic Pigs.
• IMPROVED PREDICTION OF VIROLOGICAL RESPONSE TO LOPINAVIR/RITONAVIR IN SALVAGE THERAPY USING NEW INTERPRETATION RULES OF BASELINE GENOTYPIC RESISTANCE.